Evolving Carbapenemases: Can Medicinal Chemists Advance One Step Ahead of the Coming Storm?
- 1 February 2010
- journal article
- perspective
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (8), 3013-3027
- https://doi.org/10.1021/jm9012938
Abstract
No abstract availableThis publication has 126 references indexed in Scilit:
- Docking for fragment inhibitors of AmpC β-lactamaseProceedings of the National Academy of Sciences, 2009
- Crystal Structures of Complexes of Bacterial dd-Peptidases with Peptidoglycan-Mimetic Ligands: The Substrate Specificity PuzzleJournal of Molecular Biology, 2008
- Shape Signatures: New Descriptors for Predicting Cardiotoxicity In SilicoChemical Research in Toxicology, 2008
- New Predictive Models for Blood–Brain Barrier Permeability of Drug-like MoleculesPharmaceutical Research, 2008
- Structural characterization of the zinc binding domain in cytosolic PSD‐95 interactor (cypin): Role of zinc binding in guanine deamination and dendrite branchingProteins-Structure Function and Bioinformatics, 2008
- Clustal W and Clustal X version 2.0Bioinformatics, 2007
- Role of Zinc Content on the Catalytic Efficiency of B1 Metallo β-LactamasesJournal of the American Chemical Society, 2007
- Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approachChemico-Biological Interactions, 2006
- Identification of Previously Unrecognized Antiestrogenic Chemicals Using a Novel Virtual Screening ApproachChemical Research in Toxicology, 2006
- Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptorsJournal of Computer-Aided Molecular Design, 2006